Group 6 Copy 114
-1
    Please wait...

    About This Project

    OncoSynergy, Inc.
    The Ebola outbreak in west Africa has been declared a global emergency by the WHO with over 1,000 victims and no approved therapies. OncoSynergy is developing a readily manufactured experimental cancer drug, OS2966, which coincidentally targets the receptor hijacked by ebola to infect cells. This project aims to demonstrate that OS2966 inhibits ebola infection of human cells thus providing the impetus for expediting OS2966 for treatment of ebola.
    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Aptapaper: Detecting Pathogens on a Simple Piece of Paper

    The Michigan Synthetic Biology Team is excited to be building Aptapaper, a device used to detect proteins...

    Creating a neural network that classifies Dinoflagellate species

    I think we have the technology to develop an artificial intelligence model that can differentiate between...

    The Ecological Impact of Invasive Lionfish (Pterois volitans and P. miles) in Bermuda

    A team of scientists from Bermuda is gathering data to model the ecological impact lionfish may have on...

    Backer Badge Funded

    A biology project funded by 47 people